Quantcast
Last updated on April 19, 2014 at 8:45 EDT

DuPont Reports 4Q and Full-Year 2012 EPS of $.11 and $3.33 Ex-items

January 22, 2013

WILMINGTON, Del., Jan. 22, 2013 /PRNewswire/ –

Fourth Quarter:

  • Fourth quarter 2012 earnings per share (EPS) from continuing operations, excluding significant items, was $.11 versus prior year earnings of $.26. Reported fourth quarter 2012 EPS from continuing operations was $.02 versus $.31 in the prior year.

  • Sales of $7.3 billion equaled the prior year. Three percent higher volume was offset by 2 percent negative currency impact and a 1 percent reduction from portfolio changes.

  • Segment pre-tax operating income (PTOI) was down, primarily reflecting lower price and volume in Performance Chemicals. Titanium dioxide pricing led the decline.

Full Year:

  • 2012 EPS from continuing operations, excluding significant items, was $3.33 versus $3.55 in 2011. Currency was a $.27 per share headwind for the year. Reported EPS from continuing operations was $2.61 versus $3.30 in 2011 (see Schedule B.)

  • Sales were $34.8 billion, up 3 percent with a 6 percent increase in developing markets.

  • Segment PTOI increased 3 percent to $5.7 billion, excluding Pharmaceuticals and significant items. Agriculture PTOI increased 18 percent driven by volume and pricing growth for seed and crop protection businesses in North America and Latin America. Performance Chemicals PTOI decreased 16 percent from lower sales across the segment.

  • Free cash flow was $3.1 billion versus $3.3 billion in the prior year. 2012 includes a $0.5 billion contribution to the principal U.S. pension plan and lower net income, partly offset by improved working capital productivity.

  • Fixed cost and working capital productivity benefits were each about $400 million, surpassing their
    $300 million targets.

  • Reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items, 2012 operating earnings were $3.77 per share. On the same basis, the 2013 outlook for operating earnings is $3.85 to $4.05 per share, an increase of 2 to 7 percent over the prior year.

“DuPont stands stronger today than it did a year ago. Our segments delivered innovation, productivity and integration cost synergies. This, coupled with a record year in new product introductions, has strengthened our market position,” said DuPont Chair and CEO Ellen Kullman. “However, weakness in markets served by Performance Chemicals and Electronics & Communications provided significant challenges in 2012. We’ve adjusted our plans to meet the changing market environment and grow our businesses in a slow-growth world economy.”

Global Consolidated Sales – 4(th) Quarter
Fourth quarter 2012 sales were $7.3 billion, flat versus the prior year. Currency impact and portfolio changes offset 3 percent volume growth. Volume was driven by Agriculture, with robust sales in Latin America and a strong start to the North American selling season, and increases in Asia Pacific for Performance Materials, Electronics & Communications and Performance Chemicals. The table below shows fourth quarter regional sales and variances versus fourth quarter 2011.

                             Three Months Ended  Percentage Change Due to:
                             December 31, 2012
                             -----------------
    (Dollars in billions)                       $   % Change               Local     Currency Effect     Volume     Portfolio/
                                                                           Price                                      Other
                                                                           -----                                      -----
    U.S. & Canada                            $2.5                   -             2                   -          -             (2)
    EMEA*                                     1.6                  (8)           (1)                 (4)        (2)            (1)
    Asia Pacific                              1.9                   -            (5)                 (1)         6              -
    Latin America                             1.3                  10             7                  (4)         8             (1)

    Total Consolidated Sales                 $7.3                   -             -                  (2)         3             (1)

Global Consolidated Sales – Full-Year
Full-year 2012 sales were $34.8 billion, up 3 percent versus 2011, reflecting 4 percent higher local prices, 2 percent adverse currency impact, 2 percent lower volume, and a 3 percent net increase from portfolio changes. Local prices increased for all segments except Electronics & Communications which had lower pass-through of metals prices. Lower global volume principally reflects decreases for Performance Chemicals and Electronics & Communications, partly offset by higher Agriculture volumes. The table below shows regional sales and variances versus 2011.

                                      Year Ended       Percentage Change Due to:
                                   December 31, 2012
                                   -----------------
    (Dollars in billions)                            $    % Change               Local     Currency Effect     Volume     Portfolio/
                                                                                 Price                                      Other
                                                                                 -----                                      -----
    U.S. & Canada                                $14.2                    8             6                   -          -             2
    EMEA*                                          8.1                   (1)            3                  (6)        (4)            6
    Asia Pacific                                   8.0                   (4)           (1)                 (1)        (5)            3
    Latin America                                  4.5                   11             9                  (5)         5             2

    Total Consolidated Sales                     $34.8                    3             4                  (2)        (2)            3

    * Europe, Middle East & Africa

Income from Continuing Operations – 4(th) Quarter
Excluding significant items, fourth quarter 2012 income from continuing operations was $110 million versus $246 million in the prior year. The decrease principally reflects lower income from Performance Chemicals and Pharmaceuticals, increased spending for growth initiatives and adverse currency impact. Reported fourth quarter 2012 income from continuing operations was $19 million versus $293 million in the fourth quarter 2011.

Earnings Per Share – 4(th) Quarter
The table below shows year-over-year earnings per share (EPS) variances for the fourth quarter.

                            EPS  ANALYSIS
                            -------------

                                                        4Q
                                                       ---

    EPS 2011                                            $.31
       Less: Significant items - (schedule B)            .05
                                                         ---

    EPS 2011 -Excluding significant items              .26

       Local prices                                   (.01)
       Variable cost*                                  .12
       Volume                                         (.03)
       Fixed cost*                                    (.12)
       Currency                                       (.04)
       Income tax                                      .04
       Pharmaceuticals income                         (.06)
       Other**                                        (.05)
                                                      ----

    EPS 2012 - Excluding significant items            $.11
       Add: Significant items - (schedule B)          (.09)
                                                      ----

    EPS 2012                                          $.02

    *  Excludes volume and currency impacts
    ---------------------------------------
    ** Includes interest expense, net exchange gains/losses, and other income
    -------------------------------------------------------------------------

Business Segment Performance – 4(th) Quarter
The tables below show fourth quarter 2012 segment sales with related variances versus the prior year and fourth quarter PTOI excluding significant items.

    SEGMENT SALES*                       Three Months Ended        Percentage Change
    (Dollars in billions)                December 31, 2012 Due to:
                                         ----------------- -------
                                                          $            % Change            USD      Volume     Portfolio
                                                                                          Price                and Other
                                                                                                               ---------
    Agriculture                                        $1.5                           18         7         11      -
    Electronics &
     Communications                                     0.6                           (1)       (3)         2      -
    Industrial Biosciences                              0.3                            4         1          3      -
    Nutrition & Health                                  0.9                            6         3          3      -
    Performance Chemicals                               1.6                          (15)       (7)        (8)     -
    Performance Materials                               1.5                           (5)       (5)         3            (3)
    Safety & Protection                                 1.0                            2        (1)         3             -

    *    Segment sales include transfers

    SEGMENT PTOI excluding Significant Items*                                                        Change versus
                                                                                                       2011
                                                                                                    --------------
    (Dollars in millions)                                              4Q 2012            4Q 2011                $   %
                                                                       -------            -------              ---  ---

    Agriculture                                                                $(92)              $(116)       $24       21%
    Electronics & Communications                                                 24                  42        (18)     -43%
    Industrial Biosciences                                                       44                  34         10       29%
    Nutrition & Health                                                           66                  52         14       27%
    Performance Chemicals                                                       200                 433       (233)     -54%
    Performance Materials                                                       254                 151        103       68%
    Safety & Protection                                                          88                  94         (6)      -6%
    Other                                                                       (71)                (74)         3       nm
                                                                                ---                 ---        ---
                                                                               $513                $616      $(103)     -17%
    Pharmaceuticals                                                               9                  89        (80)     -90%
                                                                                ---                 ---        ---
    Total Segment PTOI                                                         $522                $705      $(183)     -26%

    * See Schedules B and C for listing of significant items and their impact by segment.

Business Segment Performance – Full Year
The tables below show full-year 2012 segment sales with related variances versus the prior year, and full-year PTOI excluding significant items.

                                          12 Months Ended          Percentage Change
    SEGMENT SALES*                       December 31, 2012 Due to:
                                         ----------------- -------
    (Dollars in billions)
                                                         $              % Change          USD        Volume      Portfolio
                                                                                           Price                   and Other
                                                                                                                 ---------
    Agriculture                                      $10.4                            14          6           8      -
    Electronics &
     Communications                                    2.7                           (15)        (4)        (11)     -
    Industrial Biosciences                             1.2                            67         (4)          8              63
    Nutrition & Health                                 3.4                            39          1           3              35
    Performance Chemicals                              7.2                            (8)         4         (12)              -
    Performance Materials                              6.4                            (5)        (2)          -              (3)
    Safety & Protection                                3.8                            (3)         -          (3)              -

    *    Segment sales include transfers

    SEGMENT PTOI excluding Significant Items*
    (Dollars in millions)                                                                                Change versus 2011
                                                                                                         ------------------
                                                              FY 2012                     FY 2011                          $   %
                                                              -------                     -------                        ---  ---

    Agriculture                                                       $2,063                     $1,752                 $311       18%
    Electronics & Communications                                         172                        355                 (183)     -52%
    Industrial Biosciences                                               171                         78                   93      119%
    Nutrition & Health                                                   348                        170                  178      105%
    Performance Chemicals                                              1,622                      1,923                 (301)     -16%
    Performance Materials                                              1,117                        924                  193       21%
    Safety & Protection                                                  418                        500                  (82)     -16%
    Other                                                               (259)                      (235)                 (24)      nm
                                                                        ----                       ----                  ---
                                                                      $5,652                     $5,467                 $185        3%
    Pharmaceuticals                                                       62                        289                 (227)     -79%
                                                                         ---                        ---                 ----
    Total Segment PTOI                                                $5,714                     $5,756                 $(42)      -1%

    * See Schedules B and C for listing of significant items and their impact by segment.

The following is a summary of business results for each of the company’s reportable segments in the fourth quarter (unless otherwise noted), comparing current period with the prior year, for sales and PTOI (loss) excluding significant items. References to selling price are on a U.S. dollar basis, including the impact of currency.

Agriculture – Sales of $1.5 billion were up 18 percent on 11 percent higher volume and 7 percent higher prices despite the negative impact of currency. PTOI seasonal loss of ($92) million improved $24 million on higher volume in Latin America and stronger than expected pricing gains, partially offset by continued investment in commercial and R&D activities.

Full-year sales of $10.4 billion grew 14 percent on 8 percent higher volume and 6 percent higher prices. Pioneer seed sales increased from higher global volume and pricing gains in corn and soybeans. Crop Protection sales grew on strong demand for insecticides and herbicides in all regions. Full-year PTOI increased 18 percent as strong sales more than offset unfavorable currency and higher investments in commercial and R&D activities to support growth.

Electronics & Communications – Sales of $622 million were down 1 percent, with 2 percent higher volume offset by
3 percent lower prices, primarily pass-through of lower metals prices. Volume growth from increased demand for materials in smart phones and tablets was partly offset by continued softness in photovoltaic materials. PTOI declined $18 million as the prior year included OLED technology licensing income of $20 million.

Industrial Biosciences - Sales of $300 million were up 4 percent on 3 percent higher volume and 1 percent higher prices. Volume growth reflects strong sales of Sorona(®) polymer for carpeting, and continued growth in food enzymes in Europe. PTOI of $44 million was up $10 million on higher volume and the benefit of synergies realized from the integration of the Danisco enzyme business.

Nutrition & Health - Sales of $853 million were up 6 percent on 3 percent higher volume and 3 percent higher prices. Volume growth reflects strong demand for probiotics, cultures and enablers. Higher local prices in all regions were partly offset by unfavorable currency. PTOI of $66 million was up $14 million on higher sales and the benefit of synergies realized from the integration of the Danisco specialty food ingredients business, partly offset by higher raw material costs.

Performance Chemicals – Sales of $1.6 billion were down 15 percent, with 8 percent lower volume and 7 percent lower prices. Lower volume resulted primarily from weak demand for fluoropolymers in U.S. and Europe. Lower prices reflect cyclical pressure in the titanium dioxide market. PTOI of $200 million decreased $233 million on lower sales and plant utilization in both businesses.

Performance Materials – Sales of $1.5 billion were down 5 percent, with 5 percent lower prices and a 3 percent reduction from a portfolio change, partly offset by 3 percent higher volume. Stable packaging markets and strong demand in the North American automotive market were partially offset by softness in the industrial and electronics markets and a weak Europe. PTOI of $254 million increased $103 million due to lower feedstock costs, higher volume and mix enrichment, partly offset by unfavorable currency.

Safety & Protection - Sales of $964 million were up 2 percent on 3 percent higher volume, partly offset by 1 percent lower prices due to unfavorable currency. Volume increased on higher demand for Sustainable Solutions offerings and U.S. residential and commercial construction products. PTOI of $88 million decreased $6 million primarily due to lower plant utilization related to softness in certain industrial markets and U.S. public sector markets.

Additional information is available on the DuPont Investor Center website at http://www.investors.dupont.com.

Outlook
Reflecting the change in reporting for the cost of non-operating pension and other post-employment benefits and excluding significant items, 2012 operating earnings were $3.77 per share. On the same basis, the 2013 outlook for operating earnings is $3.85 to $4.05 per share, an increase of 2 to 7 percent over the prior year. First half 2013 operating earnings are expected to decline modestly on a year-over-year basis. Additionally, full-year 2013 sales are expected to be about $36 billion.

Use of Non-GAAP Measures
Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company. Such measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Reconciliations of non-GAAP measures to GAAP are provided in schedules C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company’s growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; inability to protect and enforce the company’s intellectual property rights; and integration of acquired businesses and completion of divestitures of underperforming or non-strategic assets or businesses. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

                                                                                                            E. I. du Pont de Nemours and Company
                                                                                                               Consolidated Income Statements
                                                                                                      (Dollars in millions, except per share amounts)

    SCHEDULE A
                                                                                                                                                      Three Months Ended               Year Ended
                                                                                                                                                         December 31,                 December 31,
                                                                                                                                                         ------------                 ------------
                                                                                                                                                                          2012         2011               2012        2011
                                                                                                                                                                          ----         ----               ----        ----
    Net sales                                                                                                                                                           $7,325       $7,343            $34,812     $33,681
    Other income, net(a)                                                                                                                                                   247          338                498         742
                                                                                                                                                                           ---          ---                ---         ---
    Total                                                                                                                                                                7,572        7,681             35,310      34,423

    Cost of goods sold and other operating charges (a)                                                                                                                   5,983        5,927             25,604      24,874
    Selling, general and administrative expenses                                                                                                                           842          791              3,567       3,358
    Research and development expense (a)                                                                                                                                   547          527              2,067       1,910
    Interest expense                                                                                                                                                       117          116                464         447
    Employee separation / asset related charges, net (a)                                                                                                                    99           17                493          53
                                                                                                                                                                           ---          ---                ---         ---
    Total                                                                                                                                                                7,588        7,378             32,195      30,642

    (Loss) income from continuing operations before income taxes                                                                                                           (16)         303              3,115       3,781
    (Benefit from) provision for income taxes on continuing operations                                                                                                     (35)          10                622         626
                                                                                                                                                                           ---          ---                ---         ---
    Income from continuing operations after income taxes                                                                                                                    19          293              2,493       3,155
    Net income from discontinued operations after taxes                                                                                                                     93           84                320         355
                                                                                                                                                                           ---          ---                ---         ---

    Net income                                                                                                                                                             112          377              2,813       3,510

    Less:  Net income attributable to noncontrolling interests                                                                                                               1            4                 25          36
                                                                                                                                                                           ---          ---                ---         ---

    Net income attributable to DuPont                                                                                                                                     $111         $373             $2,788      $3,474
                                                                                                                                                                          ====         ====             ======      ======

    Basic earnings per share of common stock (b):
    Basic earnings per share of common stock from continuing operations                                                                                                  $0.02        $0.31              $2.63       $3.35
    Basic earnings per share of common stock from discontinued operations                                                                                                 0.10         0.09               0.34        0.38
                                                                                                                                                                          ----         ----               ----        ----
    Basic earnings per share of common stock                                                                                                                             $0.12        $0.40              $2.98       $3.73
                                                                                                                                                                         =====        =====              =====       =====

    Diluted earnings per share of common stock (b):
    Diluted earnings per share of common stock from continuing operations                                                                                                $0.02        $0.31              $2.61       $3.30
    Diluted earnings per share of common stock from discontinued operations                                                                                               0.10         0.09               0.34        0.38
                                                                                                                                                                          ----         ----               ----        ----
    Diluted earnings per share of common stock                                                                                                                           $0.12        $0.40              $2.95       $3.68
                                                                                                                                                                         =====        =====              =====       =====

    Dividends per share of common stock                                                                                                                                  $0.43        $0.41              $1.70       $1.64
                                                                                                                                                                         =====        =====              =====       =====

    Average number of shares outstanding used in earnings per share (EPS) calculation:
      Basic                                                                                                                                                        933,420,000  925,588,000        933,275,000 928,417,000
      Diluted                                                                                                                                                      941,219,000  935,709,000        942,197,000 941,029,000

    (a) See Schedule B for detail of significant items.
    (b) The sum of the individual earnings per share amounts may not equal the total due to rounding.

                                                                                           E. I. du Pont de Nemours and Company
                                                                                           Condensed Consolidated Balance Sheets
                                                                                      (Dollars in millions, except per share amounts)

    SCHEDULE A (continued)
                                                                                                                                      December 31,          December 31,
                                                                                                                                                      2012                  2011
                                                                                                                                                      ----                  ----
    Assets
    Current assets
    Cash and cash equivalents                                                                                                                       $4,284                $3,586
    Marketable securities                                                                                                                              123                   433
    Accounts and notes receivable, net                                                                                                               5,452                 6,022
    Inventories                                                                                                                                      7,422                 7,195
    Prepaid expenses                                                                                                                                   204                   151
    Deferred income taxes                                                                                                                              650                   671
    Assets held for sale                                                                                                                             3,056                     -
    Total current assets                                                                                                                            21,191                18,058
    Property, plant and equipment, net of accumulated depreciation                                                                                  12,741                13,412
       (December 31, 2012 - $19,085; December 31, 2011 - $19,349)
    Goodwill                                                                                                                                         4,616                 5,413
    Other intangible assets                                                                                                                          5,126                 5,413
    Investment in affiliates                                                                                                                         1,163                 1,117
    Deferred income taxes                                                                                                                            3,939                 4,067
    Other assets                                                                                                                                       960                 1,012
                                                                                                                                                       ---                 -----
    Total                                                                                                                                          $49,736               $48,492
                                                                                                                                                   =======               =======

    Liabilities and Equity
    Current liabilities
    Accounts payable                                                                                                                                $4,853                $4,816
    Short-term borrowings and capital lease obligations                                                                                              1,275                   817
    Income taxes                                                                                                                                       340                   255
    Other accrued liabilities                                                                                                                        5,997                 5,297
    Liabilities related to assets held for sale                                                                                                      1,084                     -
                                                                                                                                                     -----                   ---
    Total current liabilities                                                                                                                       13,549                11,185
    Long-term borrowings and capital lease obligations                                                                                              10,465                11,736
    Other liabilities                                                                                                                               14,687                15,508
    Deferred income taxes                                                                                                                              856                 1,001
                                                                                                                                                       ---                 -----
    Total liabilities                                                                                                                               39,557                39,430
                                                                                                                                                    ------                ------

    Commitments and contingent liabilities

    Stockholders' equity
    Preferred stock                                                                                                                                    237                   237
    Common stock, $0.30 par value; 1,800,000,000 shares authorized;                                                                                    306                   304
       Issued at December 31, 2012 - 1,020,057,000; December 31, 2011 - 1,013,164,000
    Additional paid-in capital                                                                                                                      10,632                10,107
    Reinvested earnings                                                                                                                             14,286                13,422
    Accumulated other comprehensive loss                                                                                                            (8,646)               (8,750)
    Common stock held in treasury, at cost (87,041,000 shares                                                                                       (6,727)               (6,727)
       at December 31, 2012 and 2011)

    Total DuPont stockholders' equity                                                                                                               10,088                 8,593
                                                                                                                                                    ------                 -----
    Noncontrolling interests                                                                                                                            91                   469
                                                                                                                                                       ---                   ---
    Total equity                                                                                                                                    10,179                 9,062
                                                                                                                                                    ------                 -----
    Total                                                                                                                                          $49,736               $48,492
                                                                                                                                                   =======               =======

                                E. I. du Pont de Nemours and Company
                           Condensed Consolidated Statement of Cash Flows
                          (Dollars in millions, except per share amounts)

    SCHEDULE A (continued)
                                              Year Ended
                                             December 31,
                                             ------------
    Total Company                                        2012               2011
                                                         ----               ----

    Cash provided by (used for)
     operating activities                              $4,849             $5,152
                                                       ------             ------

    Investing activities
    Purchases of property,
     plant and equipment                               (1,793)            (1,843)
    Investments in affiliates                             (97)               (67)
    Payments for businesses
     (net of cash acquired)                               (18)            (6,459)
    Net (increase) decrease in
     short-term financial
     instruments                                          315              2,149
    Proceeds from sales of
     assets -net of cash sold                             302                214
    Other investing activities
     -net                                                 (55)              (232)
                                                          ---               ----
    Cash provided by (used for)
     investing activities                              (1,346)            (6,238)

    Financing activities
    Dividends paid to
     stockholders                                      (1,594)            (1,533)
    Net increase (decrease) in
     borrowings                                          (793)             1,561
    Repurchase of common stock                           (400)              (672)
    Proceeds from exercise of
     stock options                                        550                952
    Payments for noncontrolling
     interest                                            (470)                 -
    Other financing activities
     -net                                                  10                 95
                                                          ---                ---
    Cash provided by (used for)
     financing activities                              (2,697)               403

    Effect of exchange rate
     changes on cash                                      (13)                 6
                                                          ---                ---

    Cash classified as held for
     sale                                                 (95)                 -

    Increase (decrease) in cash
     and cash equivalents                                 698               (677)

    Cash and cash equivalents
     at beginning of period                             3,586              4,263
                                                        -----              -----

    Cash and cash equivalents
     at end of period                                  $4,284             $3,586
                                                       ======             ======

                                                                                                     E. I. du Pont de Nemours and Company
                                                                                           Schedule of Significant Items from Continuing Operations
                                                                                                (Dollars in millions, except per share amounts)

    SCHEDULE B
    SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS

                                                                                                                                     Pre-tax                   After-tax                ($ Per Share)
                                                                                                                                     -------                   ---------                ------------
                                                                                                                                   2012                2011            2012                       2011            2012                  2011
                                                                                                                                   ----                ----            ----                       ----            ----                  ----
    1st Quarter
    -----------
    Customer claims charge (a)                                                                                           $(50)           $       -           $(32)           $       -                  $(0.04)         $        -

    1st Quarter - Total                                                                                                  $(50)           $       -           $(32)           $       -                  $(0.04)         $        -
                                                                                                                         ====            =========           ====            =========                  ======          ==========
    2nd Quarter
    -----------
    Customer claims charge (a)                                                                                                    $(265)            $     -           $(169)                   $     -          $(0.18)             $      -
    Litigation settlement (b)                                                                                                      (137)                  -            (123)                         -           (0.13)                    -
    Gain on the sale of equity
                                                 method investment (c)                                                              122                   -              77                          -            0.08                     -
    Transition costs related to the
                                                 acquisition of Danisco(d)                                                            -                (103)              -                        (81)              -                 (0.08)
    2nd Quarter - Total                                                                                                           $(280)              $(103)          $(215)                      $(81)         $(0.23)               $(0.08)
                                                                                                                                  =====               =====           =====                       ====          ======                ======
    3rd Quarter
    -----------
    Customer claims charge (a)                                                                                          $(125)                $(75)          $(80)                $(48)                 $(0.09)             $(0.05)
    Restructuring charge (e)                                                                                                       (152)                  -            (105)                         -           (0.11)                    -
    Asset impairment charge (f)                                                                                                    (242)                  -            (157)                         -           (0.17)                    -
    Transition costs and restructuring charge
                                                 related to the acquisition of Danisco (g)                                            -                (171)              -                       (122)              -                 (0.13)
    Charge related to milestone payment
                                                 for licensing agreement (h)                                                          -                 (50)              -                        (33)              -                 (0.03)
    3rd Quarter - Total                                                                                                           $(519)              $(296)          $(342)                     $(203)         $(0.37)               $(0.21)
                                                                                                                                  =====               =====           =====                      =====          ======                ======

    4th Quarter
    -----------
    Customer claims charge (a)                                                                                          $(135)               $(100)          $(89)                $(64)                 $(0.09)             $(0.07)
    Restructuring charge/adjustments (i)                                                                                            (66)                (17)            (56)                       (11)          (0.06)                (0.01)
    Asset impairment charge (j)                                                                                                     (33)                  -             (21)                         -           (0.02)                    -
    Gain on sale of business (k)                                                                                                    117                   -              75                          -            0.08                     -
    Sale of a business (l)                                                                                                  -                   49              -                  122                       -                0.13
    4th Quarter - Total                                                                                                 $(117)                $(68)          $(91)                 $47                  $(0.09)              $0.05
                                                                                                                        =====                 ====           ====                  ===                  ======               =====

    Full Year - Total (m)                                                                                                         $(966)              $(467)          $(680)                     $(237)         $(0.72)               $(0.25)
                                                                                                                                  =====               =====           =====                      =====          ======                ======

                                           E. I. du Pont de Nemours and Company
                                 Schedule of Significant Items from Continuing Operations
                                      (Dollars in millions, except per share amounts)

    SCHEDULE B (continued)

    SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS

    (a)                    Fourth quarter 2012, third
                           quarter 2012, second quarter
                           2012, first quarter 2012,
                           fourth quarter 2011, and third
                           quarter 2011 included charges
                           of $(135), $(125), $(265),
                           $(50), $(100), and $(75),
                           respectively, recorded in Cost
                           of goods sold and other
                           operating charges associated
                           with the company's process to
                           fairly resolve claims related
                           to the use of Imprelis(R)
                           herbicide, bringing the total
                           charges to $(750) at December
                           31, 2012.  The company will
                           continue to evaluate reported
                           claim damage as additional
                           information becomes available.
                           It is reasonably possible that
                           additional charges could result
                           from this evaluation. While
                           there is a high degree of
                           uncertainty, total charges
                           could range as high as $(900).
                           The company has an applicable
                           insurance program with a
                           deductible equal to the first
                           $100 of costs and expenses. The
                           insurance program limits are
                           $725 for costs and expenses in
                           excess of the $100. The company
                           has submitted, and will
                           continue to submit, requests
                           for payment to its insurance
                           carriers for costs associated
                           with this matter.  This matter
                           relates to the Agriculture
                           segment.

    (b)                    Second quarter 2012 included a
                           charge of $(137) recorded in
                           Cost of goods sold and other
                           operating charges primarily
                           related to the company's
                           settlement of litigation with
                           Invista.  This matter is
                           included in Other.

    (c)                    Second quarter 2012 included a
                           pre-tax gain of $122 recorded
                           in Other income, net associated
                           with the sale of an equity
                           method investment in the
                           Electronics & Communications
                           segment.

    (d)                    Second quarter 2011 included
                           charges related to the Danisco
                           acquisition of $(103) recorded
                           in Cost of goods sold and other
                           operating charges.  These
                           charges included $(60) of
                           transaction costs and a $(43)
                           charge related to the fair
                           value step-up of inventories
                           that were acquired from Danisco
                           and sold in the second quarter
                           2011. Pre-tax charges by
                           segment were: Industrial
                           Biosciences - $(17), Nutrition
                           & Health - $(33), and
                           Corporate expenses - $(53).

    (e)                    Third quarter 2012 included a
                           $(152) restructuring charge
                           recorded in Employee
                           separation/asset related
                           charges, net consisting of
                           $(133) of severance and related
                           benefit costs and $(19) of
                           asset related charges as a
                           result of the company's plan to
                           eliminate corporate costs
                           previously allocated to
                           Performance Coatings and cost-
                           cutting actions to improve
                           competitiveness.  Pre-tax
                           charges by segment were:
                           Agriculture - $(3), Nutrition
                           & Health - $(13), Electronics
                           & Communications - $(7),
                           Performance Chemicals - $(3),
                           Performance Materials - $(9),
                           Safety & Protection - $(55),
                           Industrial Biosciences - $(3),
                           and Corporate expenses -
                              $(59).

    (f)                    Third quarter 2012 included a
                           $(242) impairment charge
                           recorded in Employee
                           separation/asset related
                           charges, net related to asset
                           groupings within the
                           Electronics & Communications
                           and Performance Materials
                           segments. The charge of $(150)
                           within Electronics &
                           Communications was a result of
                           conditions within the thin film
                           photovoltaic market. The charge
                           of $(92) within Performance
                           Materials was the result of
                           deteriorating conditions in an
                           industrial polymer market.

    (g)                    Third quarter 2011 included
                           charges related to the Danisco
                           acquisition of $(171).  These
                           charges included $(135)
                           recorded in Cost of goods sold
                           and other operating charges for
                           $(3) of transaction costs and a
                           $(132) charge related to the
                           fair value step-up of
                           inventories that were acquired
                           from Danisco and sold in the
                           third quarter 2011.  These
                           charges also included a $(36)
                           restructuring charge recorded
                           in Employee separation /asset
                           related charges, net related to
                           severance and related benefit
                           costs.  Pre-tax charges by
                           segment were: Industrial
                           Biosciences - $(61), Nutrition
                           & Health - $(89), Other -
                           $(18), and Corporate expenses -
                               $(3).

    (h)                    Third quarter 2011 included a
                           ($50) charge recorded in
                           Research and development
                           expense in connection with a
                           milestone payment associated
                           with a Pioneer licensing
                           agreement.

    (i)                    Fourth quarter 2012 included a
                           $(66) restructuring charge
                           recorded in Employee
                           separation/asset related
                           charges, net primarily as a
                           result of the company's plans
                           to eliminate corporate costs
                           previously allocated to
                           Performance Coatings and cost-
                           cutting actions to improve
                           competitiveness, partially
                           offset by a reversal of prior
                           year restructuring accruals.
                           Pre-tax charges by segment
                           are: Agriculture - $(8),
                           Electronics & Communications -
                           $(2), Nutrition & Health -
                           $(36), Performance Materials -
                           $(3), Safety & Protection -
                           $(3), Other - $11, and
                           Corporate expenses - $(25).
                           Fourth quarter 2011 included a
                           $(17) restructuring charge
                           recorded in Employee
                           separation/asset related
                           charges, net primarily related
                           to severance and related
                           benefit costs associated with
                           the Danisco acquisition,
                           partially offset by a reversal
                           of prior year restructuring
                           accruals.  Pre-tax charges by
                           segment were: Industrial
                           Biosciences - $(1), Nutrition
                           & Health - $(4), Performance
                           Materials - $(2), and Other -
                              $(10).

    (j)                    Fourth quarter 2012 included a
                           $(33) impairment charge
                           recorded in Employee
                           separation/asset related
                           charges, net related to an
                           asset group within the
                           Performance Chemicals segment.
                           The charge was a result of
                           strategic decisions related to
                           deteriorating conditions within
                           a specific industrial chemicals
                           market.

    (k)                    Fourth quarter 2012 included a
                           pre-tax gain of $117 recorded
                           in Other income, net associated
                           with the sale of a business
                           within the Agriculture segment.

    (l)                    Fourth quarter 2011 included a
                           pre-tax gain of $49 recorded
                           in Other income, net associated
                           with the sale of a business in
                           the Performance Materials
                           segment and a related tax
                           benefit of $73.

    (m)                    Earnings per share for the year
                           may not equal the sum of
                           quarterly earnings per share
                           due to changes in average share
                           calculations.

    See Schedule C for detail by segment.

                                                                              E. I. du Pont de Nemours and Company
                                                                                Consolidated Segment Information
                                                                                      (Dollars in millions)

    SCHEDULE C
                                                            Three Months Ended                       Year Ended
                                                               December 31,                         December 31,
                                                               ------------                         ------------
    SEGMENT SALES (1)                                                                         2012                              2011                            2012                            2011
    ----------------                                                                          ----                              ----                            ----                            ----
    Agriculture                                                                             $1,535                            $1,297                         $10,426                          $9,166
    Electronics & Communications                                                               622                               630                           2,701                           3,173
    Industrial Biosciences                                                                     300                               289                           1,180                             705
    Nutrition & Health                                                                         853                               806                           3,422                           2,460
    Performance Chemicals                                                                    1,588                             1,860                           7,188                           7,794
    Performance Materials                                                                    1,534                             1,618                           6,447                           6,815
    Safety & Protection                                                                        964                               943                           3,825                           3,934
    Other                                                                                        1                                 1                               5                              40
    Total Segment sales                                                                      7,397                             7,444                          35,194                          34,087

    Elimination of transfers                                                                   (72)                             (101)                           (382)                           (406)
    Consolidated net sales                                                                  $7,325                            $7,343                         $34,812                         $33,681
                                                                                            ======                            ======                         =======                         =======

    (1)   Sales for the reporting segments include transfers.

                                                                                 E. I. du Pont de Nemours and Company
                                                                                   Consolidated Segment Information
                                                                                         (Dollars in millions)

    SCHEDULE C (continued)
                                                                                                                      Three Months Ended    Year Ended
                                                                                                                         December 31,      December 31,
                                                                                                                         ------------      ------------
    PRE-TAX OPERATING INCOME/(LOSS) (PTOI) FROM CONTINUING OPERATIONS                                                                2012              2011    2012    2011
    -----------------------------------------------------------------                                                                ----              ----    ----    ----
    Agriculture                                                                                                                     $(118)            $(216) $1,594  $1,527
    Electronics & Communications                                                                                                       22                42     135     355
    Industrial Biosciences                                                                                                             44                33     168      (1)
    Nutrition & Health                                                                                                                 30                48     299      44
    Performance Chemicals                                                                                                             167               433   1,586   1,923
    Performance Materials                                                                                                             251               198   1,013     971
    Safety & Protection                                                                                                                85                94     360     500
    Pharmaceuticals                                                                                                                     9                89      62     289
    Other                                                                                                                             (60)              (84)   (385)   (263)
                                                                                                                                      ---               ---    ----    ----
    Total Segment PTOI                                                                                                                430               637   4,832   5,345

    Net exchange gains (losses) (1)                                                                                                   (54)              (14)   (215)   (146)
    Corporate expenses & net interest                                                                                                (392)             (320) (1,502) (1,418)
                                                                                                                                     ----              ----  ------  ------
    (Loss) income before income taxes from continuing operations                                                                     $(16)             $303  $3,115  $3,781
                                                                                                                                     ====              ====  ======  ======

                                                                                                                      Three Months Ended    Year Ended
                                                                                                                         December 31,      December 31,
                                                                                                                         ------------      ------------
    SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)                                                                                       2012              2011    2012    2011
    -----------------------------------------                                                                                        ----              ----    ----    ----
    Agriculture                                                                                                                      $(26)            $(100)  $(469)  $(225)
    Electronics & Communications                                                                                                       (2)                -     (37)      -
    Industrial Biosciences                                                                                                              -                (1)     (3)    (79)
    Nutrition & Health                                                                                                                (36)               (4)    (49)   (126)
    Performance Chemicals                                                                                                             (33)                -     (36)      -
    Performance Materials                                                                                                              (3)               47    (104)     47
    Safety & Protection                                                                                                                (3)                -     (58)      -
    Pharmaceuticals                                                                                                                     -                 -       -       -
    Other                                                                                                                              11               (10)   (126)    (28)
    Total significant items by segment                                                                                               $(92)             $(68)  $(882)  $(411)
                                                                                                                                     ====              ====   =====   =====

                                                                                                                      Three Months Ended    Year Ended
                                                                                                                         December 31,      December 31,
                                                                                                                         ------------      ------------
    PTOI EXCLUDING SIGNIFICANT ITEMS                                                                                                 2012              2011    2012    2011
    --------------------------------                                                                                                 ----              ----    ----    ----
    Agriculture                                                                                                                      $(92)            $(116) $2,063  $1,752
    Electronics & Communications                                                                                                       24                42     172     355
    Industrial Biosciences                                                                                                             44                34     171      78
    Nutrition & Health                                                                                                                 66                52     348     170
    Performance Chemicals                                                                                                             200               433   1,622   1,923
    Performance Materials                                                                                                             254               151   1,117     924
    Safety & Protection                                                                                                                88                94     418     500
    Pharmaceuticals                                                                                                                     9                89      62     289
    Other                                                                                                                             (71)              (74)   (259)   (235)
    Total Segment PTOI excluding significant items                                                                                   $522              $705  $5,714  $5,756
                                                                                                                                     ====              ====  ======  ======

    (1)  See Schedule D for additional information on exchange gains and losses.
    (2)  See Schedule B for detail of significant items.

                                                                                                                                                                                                                              E. I. du Pont de Nemours and Company
                                                                                                                                                                                                                               Reconciliation of Non-GAAP Measures
                                                                                                                                                                                                                         (Dollars in millions, except per share amounts)

    SCHEDULE D

    Summary of Earnings Comparisons

                                                                                                                                                                                    Three Months Ended                                                         Year Ended
                                                                                                                                                                                       December 31,                                                            December 31,
                                                                                                                                                                                       ------------                                                            ------------
                                                                                                                                                                                                                                                       2012                                    2011    %                2012        2011   %
                                                                                                                                                                                                                                                                                                     Change                              Change
                                                                                                                                                                                                                                                                                                     ------                              ------

    Segment PTOI                                                                                                                                                                                                                                       $430                                    $637         -32%      $4,832      $5,345        -10%
    Significant items (benefit) charge included in PTOI (per Schedule C)                                                                                                                                                                                 92                                      68                      882         411
                                                                                                                                                                                                                                                        ---                                     ---                      ---         ---
    Segment PTOI excluding significant items                                                                                                                                                                                                           $522                                    $705         -26%      $5,714      $5,756         -1%
                                                                                                                                                                                                                                                       ====                                    ====                   ======      ======

    Income from continuing operations after income taxes                                                                                                                                                                                                $19                                    $293         -94%      $2,493      $3,155        -21%
    Significant items (benefit) charge included in income from
    continuing operations after income taxes (per Schedule B)                                                                                                                                                                                            91                                     (47)                     680         237
    Income from continuing operations after income taxes, excluding significant items                                                                                                                                                                  $110                                    $246         -55%      $3,173      $3,392         -6%
                                                                                                                                                                                                                                                       ====                                    ====                   ======      ======

    EPS from continuing operations                                                                                                                                                                                                                    $0.02                                   $0.31         -94%       $2.61       $3.30        -21%
    Significant items (benefit) charge included in EPS (per Schedule B)                                                                                                                                                                                0.09                                   (0.05)                    0.72        0.25
                                                                                                                                                                                                                                                       ----                                   -----                     ----        ----
    EPS from continuing operations, excluding significant items                                                                                                                                                                                       $0.11                                   $0.26         -58%       $3.33       $3.55         -6%
                                                                                                                                                                                                                                                      =====                                   =====                    =====       =====

    Average number of diluted shares outstanding                                                                                                                                                                                                941,219,000                             935,709,000           1% 942,197,000 941,029,000          0%

    Reconciliation of Operating Earnings Per Share (EPS) Outlook
    The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs, as presented on December 13, 2012.

                                                                                                                                                                                                                              Year Ended December 31,
                                                                                                                                                                                                                              -----------------------
                                                                                                                                                                                                                                   2013 Outlook                             2012 Actual
                                                                                                                                                                                                                                   ------------                             -----------
    Operating EPS                                                                                                                                                                                                                             $3.85 - $4.05                                   $3.77

    Significant items
    -----------------
    1Q 2013 U.S. tax law items retroactive to 2012 - estimate                                                                                                                                                                                          0.07                                       -
    Sale of an equity method investment                                                                                                                                                                                                                                                        0.08
    Customer claims charges                                                                                                                                                                                                                                                                   (0.39)
    Restructuring charge/adjustments                                                                                                                                                                                                                                                          (0.17)
    Litigation settlement                                                                                                                                                                                                                                                                     (0.13)
    Asset impairment charge                                                                                                                                                                                                                                                                   (0.19)
    Sale of business                                                                                                                                                                                                                                                                           0.08

    Non-operating pension/OPEB costs - estimate                                                                                                                                                                                                       (0.42)                                  (0.47)

    Impact of LIFO accounting change                                                                                                                                                                                                                      -                                    0.03

    Reported EPS from continuing operations                                                                                                                                                                                                   $3.50 - $3.70                                   $2.61
                                                                                                                                                                                                                                              -------------                                   -----

                                                                                E. I. du Pont de Nemours and Company
                                                                                 Reconciliation of Non-GAAP Measures
                                                                                        (Dollars in millions)

    SCHEDULE D

    Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements

                                                                                                                     Three Months Ended                     Year Ended
                                                                                                                        December 31,                       December 31,
                                                                                                                        ------------                       ------------
                                                                                                                                                     2012                 2011   2012   2011
                                                                                                                                                     ----                 ----   ----   ----

    (Loss) income from continuing operations before income taxes                                                                                     $(16)                $303 $3,115 $3,781
    Less: Net income attributable to noncontrolling interests                                                                                           1                    4     25     36
    Add:  Interest expense                                                                                                                            117                  116    464    447
                                                                                                                                                      ---                  ---    ---    ---
    Adjusted EBIT from continuing operations                                                                                                          100                  415  3,554  4,192
    Add: Depreciation and amortization                                                                                                                394                  393  1,631  1,451
                                                                                                                                                      ---                  ---  -----  -----
    Adjusted EBITDA from continuing operations                                                                                                       $494                 $808 $5,185 $5,643
                                                                                                                                                     ====                 ==== ====== ======

    Calculation of Free Cash Flow - Total Company

                                                                                                                                         Year Ended
                                                                                                                                        December 31,
                                                                                                                                        ------------

                                                                                                                                                     2012                 2011
                                                                                                                                                     ----                 ----
    Cash provided by (used for) operating activities                                                                                               $4,849               $5,152
    Less: Purchases of property, plant and equipment                                                                                                1,793                1,843
    Free cash flow                                                                                                                                 $3,056               $3,309
                                                                                                                                                   ======               ======

                                                                                                                                                                         E. I. du Pont de Nemours and Company
                                                                                                                                                                         Reconciliation of Non-GAAP Measures
                                                                                                                                                                                (Dollars in millions)

    SCHEDULE D (continued)

    Exchange Gains/Losses
    The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the
     effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements.

                                                                                                                                                                                                                          Three Months Ended                            Year Ended
                                                                                                                                                                                                                             December 31,                              December 31,
                                                                                                                                                                                                                             ------------                              ------------
                                                                                                                                                                                                                                            2012                                       2011                                     2012                                       2011
                                                                                                                                                                                                                                            ----                                       ----                                     ----                                       ----
    Subsidiary/Affiliate Monetary Position Gain (Loss)
    --------------------------------------------------
    Pre-tax exchange gains (losses) (includes equity affiliates)                                                                                                                                                                             $(8)                                      $(83)                                    $(58)                                      $(13)
    Local tax benefits (expenses)                                                                                                                                                                                                              9                                          4                                       19                                         35
                                                                                                                                                                                                                                             ---                                        ---                                      ---                                        ---
    Net after-tax impact from subsidiary exchange gains (losses)                                                                                                                                                                              $1                                       $(79)                                    $(39)                                       $22
                                                                                                                                                                                                                                             ===                                       ====                                     ====                                        ===

    Hedging Program Gain (Loss)
    --------------------------
    Pre-tax exchange gains (losses)                                                                                                                                                                                                         $(46)                                       $69                                    $(157)                                     $(133)
    Tax benefits (expenses)                                                                                                                                                                                                                   16                                        (24)                                      54                                         46
                                                                                                                                                                                                                                             ---                                        ---                                      ---                                        ---
    Net after-tax impact from hedging program exchange gains (losses)                                                                                                                                                                       $(30)                                       $45                                    $(103)                                      $(87)
                                                                                                                                                                                                                                            ====                                        ===                                    =====                                       ====

    Total Exchange Gain (Loss)
    -------------------------
    Pre-tax exchange gains (losses)                                                                                                                                                                                                         $(54)                                      $(14)                                   $(215)                                     $(146)
    Tax benefits (expenses)                                                                                                                                                                                                                   25                                        (20)                                      73                                         81
                                                                                                                                                                                                                                             ---                                        ---                                      ---                                        ---
    Net after-tax exchange gains (losses) (1)                                                                                                                                                                                               $(29)                                      $(34)                                   $(142)                                      $(65)
                                                                                                                                                                                                                                            ====                                       ====                                    =====                                       ====

    As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

    (1)  The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $(3) and $(5) for the three months ended December 31, 2012 and 2011, respectively, and $(14) and $(17) for the year ended December 31, 2012 and 2011, respectively.

    Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
    Base income tax rate is defined as the effective income tax rate less the effect of exchange gains/losses, as defined above, and significant items.

                                                                                                                                                                                                                          Three Months Ended                            Year Ended
                                                                                                                                                                                                                             December 31,                              December 31,
                                                                                                                                                                                                                             ------------                              ------------
                                                                                                                                                                                                                                            2012                                       2011                                     2012                                       2011
                                                                                                                                                                                                                                            ----                                       ----                                     ----                                       ----

    (Loss) income from continuing operations before income taxes                                                                                                                                                                            $(16)                                      $303                                   $3,115                                     $3,781
    Add:  Significant items - (benefit) charge (2)                                                                                                                                                                                           117                                         68                                      966                                        467
    Less:  Net exchange (losses) gains                                                                                                                                                                                                       (54)                                       (14)                                    (215)                                      (146)
                                                                                                                                                                                                                                             ---                                        ---                                     ----                                       ----
    Income from continuing operations before income taxes, significant items and exchange
    gains/losses                                                                                                                                                                                                                            $155                                       $385                                   $4,296                                     $4,394
                                                                                                                                                                                                                                            ====                                       ====                                   ======                                     ======

    (Benefit from) provision for income taxes on continuing operations                                                                                                                                                                      $(35)                                       $10                                     $622                                       $626
    Add:  Tax benefit (expenses) on significant items                                                                                                                                                                                         26                                        115                                      286                                        230
              Tax benefits (expenses) on exchange gains/losses                                                                                                                                                                                25                                        (20)                                      73                                         81
                                                                                                                                                                                                                                             ---                                        ---                                      ---                                        ---
    Provision for income taxes on continuing operations, excluding taxes on significant items                                                                                                                                                $16                                       $105                                     $981                                       $937
          and exchange gains/losses

    Effective income tax rate                                                                                                                                                                                                              218.8%                                       3.3%                                    20.0%                                      16.6%
    Significant items effect                                                                                                                                                                                                             (227.7%)                                      30.4%                                     2.2%                                       3.6%
                                                                                                                                                                                                                                         -------                                       ----                                      ---                                        ---
    Tax rate, from continuing operations, before significant items                                                                                                                                                                         (8.9%)                                      33.7%                                    22.2%                                      20.2%
    Exchange gains (losses) effect                                                                                                                                                                                                          19.2%                                     (6.4%)                                     0.6%                                       1.1%
                                                                                                                                                                                                                                            ----                                      -----                                      ---                                        ---
    Base income tax rate from continuing operations                                                                                                                                                                                         10.3%                                      27.3%                                    22.8%                                      21.3%
                                                                                                                                                                                                                                            ====                                       ====                                     ====                                       ====

    (2)  See Schedule B for detail of significant items.

                                                         E. I. du Pont de Nemours and Company
                                                           Consolidated Segment Information
                                                                (Dollars in millions)

    SCHEDULE E
    Below represents the company's estimated 4Q and Full Year 2012 segment operating earnings reflecting the change in
     reporting for the cost of non-operating pension and other post-employment benefits and excluding significant
     items.

                                                         Three Months Ended                       Year Ended
                                                            December 31,                         December 31,
                                                            ------------                         ------------
    SEGMENT OPERATING EARNINGS                                             2012                                 2012
    --------------------------                                             ----                                 ----
    Agriculture                                                            $(78)                              $2,138
    Electronics & Communications                                             43                                  259
    Industrial Biosciences                                                   42                                  162
    Nutrition & Health                                                       58                                  326
    Performance Chemicals                                                   237                                1,814
    Performance Materials                                                   273                                1,225
    Safety & Protection                                                     133                                  620
    Pharmaceuticals                                                           9                                   62
    Other                                                                  (101)                                (355)
    Total Segment Operating Earnings                                        616                                6,251

    Significant items benefit
     (charge)(1)                                                            (92)                                (882)
    Non-operating pension/OPEB costs                                       (144)                                (615)
    LIFO/Other reporting changes                                             50                                   78
    Total Segment PTOI                                                     $430                               $4,832
                                                                           ====                               ======

    (1)  See Schedule B for detail of significant items.

SOURCE DuPont


Source: PR Newswire